Lasalle Investment Management Securities LLC Cuts Stock Position in Healthpeak Properties, Inc. (NYSE:DOC)

Lasalle Investment Management Securities LLC decreased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 86.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 461,465 shares of the real estate investment trust’s stock after selling 3,062,026 shares during the period. Lasalle Investment Management Securities LLC’s holdings in Healthpeak Properties were worth $9,354,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Mizuho Bank Ltd. purchased a new position in Healthpeak Properties during the fourth quarter valued at $28,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Healthpeak Properties during the 4th quarter worth about $30,000. Covestor Ltd lifted its stake in Healthpeak Properties by 173.8% in the 4th quarter. Covestor Ltd now owns 1,815 shares of the real estate investment trust’s stock valued at $37,000 after buying an additional 1,152 shares in the last quarter. AdvisorNet Financial Inc boosted its holdings in Healthpeak Properties by 34.5% in the 4th quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock worth $44,000 after buying an additional 563 shares during the last quarter. Finally, Kestra Investment Management LLC purchased a new stake in Healthpeak Properties during the 4th quarter worth approximately $45,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on DOC shares. Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. StockNews.com lowered shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a report on Monday, April 14th. Robert W. Baird reduced their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Scotiabank lowered their price target on shares of Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating on the stock in a research report on Friday, February 28th. Finally, Wedbush reiterated an “outperform” rating and issued a $24.00 price objective on shares of Healthpeak Properties in a report on Friday, April 11th. One analyst has rated the stock with a sell rating, three have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Healthpeak Properties has an average rating of “Moderate Buy” and a consensus target price of $23.83.

Healthpeak Properties Price Performance

NYSE:DOC opened at $18.75 on Friday. Healthpeak Properties, Inc. has a 52 week low of $17.33 and a 52 week high of $23.26. The stock’s fifty day moving average is $19.68 and its two-hundred day moving average is $20.68. The company has a market capitalization of $13.11 billion, a P/E ratio of 53.56, a P/E/G ratio of 2.17 and a beta of 1.02. The company has a quick ratio of 1.35, a current ratio of 1.35 and a debt-to-equity ratio of 0.96.

Healthpeak Properties Announces Dividend

The business also recently announced a dividend, which will be paid on Wednesday, April 30th. Shareholders of record on Friday, April 18th will be given a $0.1017 dividend. The ex-dividend date is Thursday, April 17th. This represents a yield of 6.5%. Healthpeak Properties’s payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.